Insulin perception among insulin-naïve type-2 diabetes mellitus patients in Pakistan

Tahir Mehmood Khan,Ahsan Saleem,Albert Lee,Imran Masood

doi:10.1080/2331205x.2016.1229374

Tahir Mehmood Khan, Ahsan Saleem + Show 2 more

Open Access

https://doi.org/10.1080/2331205x.2016.1229374

Copy DOI

Abstract

AbstractThis cross sectional study was conducted to assess insulin perception among insulin naive type-2 diabetes mellitus (T2DM) patients who attended an outpatient department in a tertiary care hospital in Pakistan. A total of 160 T2DM patients participated in the study, whereby the majority (64.4%) were females, nearly 50% were jobless and 20% were doing a government job. Nearly 65% patients were unwilling to use insulin and approximately every 9 in 10 (90%) patients had negative perception regarding insulin therapy. Furthermore, the insulin perception was significantly associated with the gender (95% CI = 8.691–16.378; p < 0.001), level of education (95% CI = 0.835–4.577; p < 0.005), and monthly income (95% CI = 0.071–3.785; p < 0.042) of patients. In conclusion, the majority of insulin-naive T2DM patients were unwilling to initiate the insulin therapy due to their negative perception. Therefore, healthcare professionals should provide sufficient information regarding insulin therapy and try their bes...

Highlights

Diabetes mellitus (DM) is a chronic metabolic disease and a growing public health concern worldwide (Hu, 2011)
type 2 DM (T2DM) patients aged
15–20 min were given to each patient for filling out the Insulin Perception Questionnaire (IPQ)

Summary

Introduction

Diabetes mellitus (DM) is a chronic metabolic disease and a growing public health concern worldwide (Hu, 2011). DM affects every 1 in 11 adults, and approximately every 6 s, a person dies from diabetes (International Diabetes Federation, 2015). In 2014, around 387 million of the global population had DM (International Diabetes Federation, 2014). Diabetes Mellitus, especially type 2 DM (T2DM), is more prevalent in Asian countries as compared to Western industrialized countries due to rapid urbanization, poor living standards, and inadequate healthcare facilities, and putting a substantial cost burden on patients (Afroz et al, 2015; Jabbar, Hameed, Chawla, & Akhter, 2008). The slowly progressing nature of T2DM leads patients to a stage when oral anti-diabetic therapy fails to control the glycaemic levels alone and the initiation of insulin therapy becomes an essential approach to achieve the required glycaemic values, and to maintain HbA1C level below 7.0% (Wong et al, 2011)

Methods

Results

Discussion

Conclusion